Article
Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma.
The Journal of clinical endocrinology and metabolism - 1 Feb 2009
Howell Viive M, Gill Anthony, Clarkson Adele, Nelson Anne E, Dunne Robert, Delbridge Leigh W, Robinson Bruce G, Teh Bin T, Gimm Oliver, Marsh Deborah J
Abstract excerpt
CONTEXT: Parafibromin, encoded by HRPT2, is the first marker with significant benefit in the diagnosis of parathyroid carcinoma. However, because parafibromin is only involved in up to 70% of parathyroid carcinomas and loss of parafibromin immunoreactivity may not be observed in all cases of HRPT2 mutation, a complementary marker is needed. OBJECTIVE: We sought to determine the efficacy of increased expression of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
